Vanguard Portfolio Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Vanguard Portfolio Management's GH Position: Q2 2026 in Review
Vanguard Portfolio Management reduced its Guardant Health (GH) stake by 6.7% in Q2 2026, selling an estimated $42.7M and leaving 5,445,785 shares worth $817M. The position accounts for 0.04% of the portfolio, ranked #506.
Vanguard Portfolio Management first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 550 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Vanguard Portfolio Management held 5,445,785 shares of Guardant Health worth $817M as of Q2 2026.
- Vanguard Portfolio Management sold 392,207 Guardant Health shares in Q2 2026, an estimated $42.7M.
- Guardant Health made up 0.04% of Vanguard Portfolio Management's portfolio in Q2 2026, its #506 holding.
- Vanguard Portfolio Management first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
- 550 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.